CI Health Care Giants Covered Call ETF (FHI.TO) is an income-focused exchange-traded fund that primarily invests in large-cap healthcare companies while employing a covered call strategy to enhance yield. The ETF targets established firms in the healthcare sector, including pharmaceuticals and biotechnology, primarily in North America, leveraging the stability of these companies to provide consistent income to investors.
The ETF generates revenue through management fees based on the total assets under management, which is enhanced by the covered call strategy that generates additional income from option premiums. This model benefits from the stability and growth potential of large-cap healthcare stocks, providing a dual income stream.
Performance of underlying healthcare stocks, particularly large-cap firms like Johnson & Johnson and Pfizer
Volatility in the options market affecting premium income from covered calls
Changes in interest rates impacting investor appetite for income-generating investments
Overall market sentiment towards healthcare sector investments
Regulatory changes impacting the healthcare sector
Technological disruption in healthcare delivery and pharmaceuticals
Increased competition from other income-focused ETFs
Market volatility affecting the performance of covered call strategies
Minimal debt levels as an ETF typically does not carry debt
Liquidity risks associated with large redemptions
moderate - The healthcare sector is generally resilient during economic downturns, but demand for elective procedures can be sensitive to economic conditions.
Rising interest rates can lead to higher yields on bonds, making fixed-income investments more attractive compared to equity income strategies like covered calls, potentially reducing demand for the ETF.
minimal - The ETF is not heavily reliant on credit markets as it primarily invests in equities.
income - The ETF appeals to income-focused investors seeking yield through a conservative investment strategy.
moderate - The ETF's volatility is expected to be lower than the broader market due to its focus on large-cap, stable healthcare companies.